APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bupropion Hydrochloride Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Bupropion Hydrochloride Extended-Release Tablets Industry Research Report 2026

31 December 2025129 pages

Choose your research edition.

Industry ResearchBupropion Hydrochloride Extended-Release Tablets Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Bupropion Hydrochloride Extended-Release Tablets Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Bupropion Hydrochloride Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bupropion Hydrochloride Extended-Release Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bupropion Hydrochloride Extended-Release Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Bupropion Hydrochloride Extended-Release Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Bupropion Hydrochloride Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Bupropion Hydrochloride Extended-Release Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Bupropion Hydrochloride Extended-Release Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Bupropion Hydrochloride Extended-Release Tablets include Annora Pharma, Dr. Reddy's, Epic Pharma, Granules India, Impax Laboratories, ProPhase, Teva Pharmaceuticals, Valeant International Barbados SRL and Disha, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Bupropion Hydrochloride Extended-Release Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Bupropion Hydrochloride Extended-Release Tablets Market by Company

Annora Pharma

Dr. Reddy's

Epic Pharma

Granules India

Impax Laboratories

ProPhase

Teva Pharmaceuticals

Valeant International Barbados SRL

Disha

GlaxoSmithKline

Shenyang Funing Pharmaceutical

Venturepharm Pharmacetical

Sinotherapeutics

Yichang Humanwell Pharmaceutical

Bupropion Hydrochloride Extended-Release Tablets Segment by Type

150mg

300mg

Bupropion Hydrochloride Extended-Release Tablets Segment by Application

Pharmacy

Hospital

Clinic

Bupropion Hydrochloride Extended-Release Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bupropion Hydrochloride Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bupropion Hydrochloride Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bupropion Hydrochloride Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Bupropion Hydrochloride Extended-Release Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Bupropion Hydrochloride Extended-Release Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Bupropion Hydrochloride Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bupropion Hydrochloride Extended-Release Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Bupropion Hydrochloride Extended-Release Tablets Sales (Units) of Manufacturers (2021-2026) Table 7. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Bupropion Hydrochloride Extended-Release Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Bupropion Hydrochloride Extended-Release Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Bupropion Hydrochloride Extended-Release Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Product Type & Application Table 14. Global Bupropion Hydrochloride Extended-Release Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Bupropion Hydrochloride Extended-Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Annora Pharma Company Information Table 19. Annora Pharma Business Overview Table 20. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 22. Annora Pharma Recent Developments Table 23. Dr. Reddy's Company Information Table 24. Dr. Reddy's Business Overview Table 25. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 27. Dr. Reddy's Recent Developments Table 28. Epic Pharma Company Information Table 29. Epic Pharma Business Overview Table 30. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 32. Epic Pharma Recent Developments Table 33. Granules India Company Information Table 34. Granules India Business Overview Table 35. Granules India Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 37. Granules India Recent Developments Table 38. Impax Laboratories Company Information Table 39. Impax Laboratories Business Overview Table 40. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 42. Impax Laboratories Recent Developments Table 43. ProPhase Company Information Table 44. ProPhase Business Overview Table 45. ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 47. ProPhase Recent Developments Table 48. Teva Pharmaceuticals Company Information Table 49. Teva Pharmaceuticals Business Overview Table 50. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 52. Teva Pharmaceuticals Recent Developments Table 53. Valeant International Barbados SRL Company Information Table 54. Valeant International Barbados SRL Business Overview Table 55. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 57. Valeant International Barbados SRL Recent Developments Table 58. Disha Company Information Table 59. Disha Business Overview Table 60. Disha Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 62. Disha Recent Developments Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 67. GlaxoSmithKline Recent Developments Table 68. Shenyang Funing Pharmaceutical Company Information Table 69. Shenyang Funing Pharmaceutical Business Overview Table 70. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 72. Shenyang Funing Pharmaceutical Recent Developments Table 73. Venturepharm Pharmacetical Company Information Table 74. Venturepharm Pharmacetical Business Overview Table 75. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 77. Venturepharm Pharmacetical Recent Developments Table 78. Sinotherapeutics Company Information Table 79. Sinotherapeutics Business Overview Table 80. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 82. Sinotherapeutics Recent Developments Table 83. Yichang Humanwell Pharmaceutical Company Information Table 84. Yichang Humanwell Pharmaceutical Business Overview Table 85. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio Table 87. Yichang Humanwell Pharmaceutical Recent Developments Table 88. Global Bupropion Hydrochloride Extended-Release Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2021-2026) & (Units) Table 90. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 91. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region (2027-2032) & (Units) Table 92. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Region (2027-2032) Table 93. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2021-2026) Table 95. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Region (2027-2032) Table 97. North America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 99. North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 100. North America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 104. Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 105. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 109. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 110. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 114. South America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 115. South America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2026) & (Units) Table 119. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2027-2032) & (Units) Table 120. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2026) & (Units) Table 123. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2027-2032) & (Units) Table 124. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2026) Table 125. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2027-2032) Table 126. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2026) Table 129. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2027-2032) Table 130. Global Bupropion Hydrochloride Extended-Release Tablets Price by Type (2021-2026) & (US$/Unit) Table 131. Global Bupropion Hydrochloride Extended-Release Tablets Price by Type (2027-2032) & (US$/Unit) Table 132. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2026) & (Units) Table 133. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2027-2032) & (Units) Table 134. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2026) Table 135. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2027-2032) Table 136. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2026) Table 139. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2027-2032) Table 140. Global Bupropion Hydrochloride Extended-Release Tablets Price by Application (2021-2026) & (US$/Unit) Table 141. Global Bupropion Hydrochloride Extended-Release Tablets Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Bupropion Hydrochloride Extended-Release Tablets Distributors List Table 145. Bupropion Hydrochloride Extended-Release Tablets Customers List Table 146. Bupropion Hydrochloride Extended-Release Tablets Industry Trends Table 147. Bupropion Hydrochloride Extended-Release Tablets Industry Drivers Table 148. Bupropion Hydrochloride Extended-Release Tablets Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Bupropion Hydrochloride Extended-Release Tablets Product Image Figure 5. Global Bupropion Hydrochloride Extended-Release Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Bupropion Hydrochloride Extended-Release Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Bupropion Hydrochloride Extended-Release Tablets Sales (2021-2032) & (Units) Figure 8. Global Bupropion Hydrochloride Extended-Release Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. 150mg Product Image Figure 10. 300mg Product Image Figure 11. Pharmacy Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Bupropion Hydrochloride Extended-Release Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Bupropion Hydrochloride Extended-Release Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region in 2025 Figure 20. Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region in 2025 Figure 21. North America Bupropion Hydrochloride Extended-Release Tablets Market Size by Country in 2025 Figure 22. North America Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Bupropion Hydrochloride Extended-Release Tablets Market Size by Country in 2025 Figure 27. Europe Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 28. Europe Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2021-2032) Figure 29. Germany Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Nordic Countries Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Market Size by Country in 2025 Figure 36. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2021-2032) Figure 38. China Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Bupropion Hydrochloride Extended-Release Tablets Market Size by Country in 2025 Figure 47. South America Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 48. South America Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2021-2032) Figure 49. Mexico Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Market Size by Country in 2025 Figure 53. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Country (2021-2032) Figure 55. Turkey Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Bupropion Hydrochloride Extended-Release Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2032) Figure 59. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2032) Figure 60. Global Bupropion Hydrochloride Extended-Release Tablets Price (US$/Unit) by Type (2021-2032) Figure 61. Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2032) Figure 62. Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2032) Figure 63. Global Bupropion Hydrochloride Extended-Release Tablets Price (US$/Unit) by Application (2021-2032) Figure 64. Bupropion Hydrochloride Extended-Release Tablets Value Chain Figure 65. Bupropion Hydrochloride Extended-Release Tablets Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • 150mg
  • 300mg
Applications
  • Pharmacy
  • Hospital
  • Clinic
Companies covered
  • Annora Pharma
  • Dr. Reddy's
  • Epic Pharma
  • Granules India
  • Impax Laboratories
  • ProPhase
  • Teva Pharmaceuticals
  • Valeant International Barbados SRL
  • Disha
  • GlaxoSmithKline
  • Shenyang Funing Pharmaceutical
  • Venturepharm Pharmacetical
  • Sinotherapeutics
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Market Size (2021-2032)
  4. 2.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales (2021-2032)
  5. 2.2.3 Global Bupropion Hydrochloride Extended-Release Tablets Market Average Price (2021-2032)
  6. 2.3 Bupropion Hydrochloride Extended-Release Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 150mg
  9. 2.3.3 300mg
  10. 2.4 Bupropion Hydrochloride Extended-Release Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Pharmacy
  13. 2.4.3 Hospital
  14. 2.4.4 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Bupropion Hydrochloride Extended-Release Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Bupropion Hydrochloride Extended-Release Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Bupropion Hydrochloride Extended-Release Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Bupropion Hydrochloride Extended-Release Tablets, Established Date
  9. 3.9 Global Bupropion Hydrochloride Extended-Release Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Annora Pharma
  2. 4.1.1 Annora Pharma Company Information
  3. 4.1.2 Annora Pharma Business Overview
  4. 4.1.3 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Annora Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  6. 4.1.5 Annora Pharma Recent Developments
  7. 4.2 Dr. Reddy's
  8. 4.2.1 Dr. Reddy's Company Information
  9. 4.2.2 Dr. Reddy's Business Overview
  10. 4.2.3 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  12. 4.2.5 Dr. Reddy's Recent Developments
  13. 4.3 Epic Pharma
  14. 4.3.1 Epic Pharma Company Information
  15. 4.3.2 Epic Pharma Business Overview
  16. 4.3.3 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Epic Pharma Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  18. 4.3.5 Epic Pharma Recent Developments
  19. 4.4 Granules India
  20. 4.4.1 Granules India Company Information
  21. 4.4.2 Granules India Business Overview
  22. 4.4.3 Granules India Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Granules India Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  24. 4.4.5 Granules India Recent Developments
  25. 4.5 Impax Laboratories
  26. 4.5.1 Impax Laboratories Company Information
  27. 4.5.2 Impax Laboratories Business Overview
  28. 4.5.3 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Impax Laboratories Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  30. 4.5.5 Impax Laboratories Recent Developments
  31. 4.6 ProPhase
  32. 4.6.1 ProPhase Company Information
  33. 4.6.2 ProPhase Business Overview
  34. 4.6.3 ProPhase Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 ProPhase Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  36. 4.6.5 ProPhase Recent Developments
  37. 4.7 Teva Pharmaceuticals
  38. 4.7.1 Teva Pharmaceuticals Company Information
  39. 4.7.2 Teva Pharmaceuticals Business Overview
  40. 4.7.3 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teva Pharmaceuticals Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  42. 4.7.5 Teva Pharmaceuticals Recent Developments
  43. 4.8 Valeant International Barbados SRL
  44. 4.8.1 Valeant International Barbados SRL Company Information
  45. 4.8.2 Valeant International Barbados SRL Business Overview
  46. 4.8.3 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Valeant International Barbados SRL Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  48. 4.8.5 Valeant International Barbados SRL Recent Developments
  49. 4.9 Disha
  50. 4.9.1 Disha Company Information
  51. 4.9.2 Disha Business Overview
  52. 4.9.3 Disha Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Disha Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  54. 4.9.5 Disha Recent Developments
  55. 4.10 GlaxoSmithKline
  56. 4.10.1 GlaxoSmithKline Company Information
  57. 4.10.2 GlaxoSmithKline Business Overview
  58. 4.10.3 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 GlaxoSmithKline Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  60. 4.10.5 GlaxoSmithKline Recent Developments
  61. 4.11 Shenyang Funing Pharmaceutical
  62. 4.11.1 Shenyang Funing Pharmaceutical Company Information
  63. 4.11.2 Shenyang Funing Pharmaceutical Business Overview
  64. 4.11.3 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shenyang Funing Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  66. 4.11.5 Shenyang Funing Pharmaceutical Recent Developments
  67. 4.12 Venturepharm Pharmacetical
  68. 4.12.1 Venturepharm Pharmacetical Company Information
  69. 4.12.2 Venturepharm Pharmacetical Business Overview
  70. 4.12.3 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Venturepharm Pharmacetical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  72. 4.12.5 Venturepharm Pharmacetical Recent Developments
  73. 4.13 Sinotherapeutics
  74. 4.13.1 Sinotherapeutics Company Information
  75. 4.13.2 Sinotherapeutics Business Overview
  76. 4.13.3 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sinotherapeutics Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  78. 4.13.5 Sinotherapeutics Recent Developments
  79. 4.14 Yichang Humanwell Pharmaceutical
  80. 4.14.1 Yichang Humanwell Pharmaceutical Company Information
  81. 4.14.2 Yichang Humanwell Pharmaceutical Business Overview
  82. 4.14.3 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Yichang Humanwell Pharmaceutical Bupropion Hydrochloride Extended-Release Tablets Product Portfolio
  84. 4.14.5 Yichang Humanwell Pharmaceutical Recent Developments
5 Global Bupropion Hydrochloride Extended-Release Tablets Market Scenario by Region
  1. 5.1 Global Bupropion Hydrochloride Extended-Release Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Region: 2027-2032
  5. 5.3 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Bupropion Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Bupropion Hydrochloride Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Bupropion Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
  15. 5.5.1 Europe Bupropion Hydrochloride Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  17. 5.5.3 Europe Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Bupropion Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
  36. 5.7.1 South America Bupropion Hydrochloride Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  38. 5.7.3 South America Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Bupropion Hydrochloride Extended-Release Tablets Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Bupropion Hydrochloride Extended-Release Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Bupropion Hydrochloride Extended-Release Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Bupropion Hydrochloride Extended-Release Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Bupropion Hydrochloride Extended-Release Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Bupropion Hydrochloride Extended-Release Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Bupropion Hydrochloride Extended-Release Tablets Value Chain Analysis
  2. 8.1.1 Bupropion Hydrochloride Extended-Release Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Bupropion Hydrochloride Extended-Release Tablets Production Mode & Process
  5. 8.2 Bupropion Hydrochloride Extended-Release Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Bupropion Hydrochloride Extended-Release Tablets Distributors
  8. 8.2.3 Bupropion Hydrochloride Extended-Release Tablets Customers
9 Global Bupropion Hydrochloride Extended-Release Tablets Analyzing Market Dynamics
  1. 9.1 Bupropion Hydrochloride Extended-Release Tablets Industry Trends
  2. 9.2 Bupropion Hydrochloride Extended-Release Tablets Industry Drivers
  3. 9.3 Bupropion Hydrochloride Extended-Release Tablets Industry Opportunities and Challenges
  4. 9.4 Bupropion Hydrochloride Extended-Release Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst